Avita Medical
RCEL
69 hedge funds and large institutions have $148M invested in Avita Medical in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.71% less ownership
Funds ownership: 35.16% → 33.45% (-1.7%)
3% less funds holding
Funds holding: 71 → 69 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
18% less capital invested
Capital invested by funds: $180M → $148M (-$31.7M)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
85% less call options, than puts
Call options by funds: $243K | Put options by funds: $1.57M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$773K |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$431K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$323K |
| 4 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$301K |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$287K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.67M |
| 2 |
Goldman Sachs
New York
|
-$2.54M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.51M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$1.22M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$633K |
RCEL Hedge Fund Activity: Q3 2021 in Review
69 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q3 2021, worth a combined $148M — down 18% from $180M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RCEL and 5 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 18 added.
The largest buyer was JP Morgan Chase, adding an estimated $773K. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $2.67M sold.
- 69 institutional investors held Avita Medical (RCEL) as of Q3 2021, down from 71 in Q2 2021.
- Funds reported $148M of Avita Medical stock for Q3 2021, down 18% quarter-over-quarter.
- 5 funds opened new Avita Medical positions in Q3 2021 and 6 closed out, a net change of -1 holder.
- The largest Avita Medical buyer in Q3 2021 was JP Morgan Chase, an estimated $773K added.
- The largest Avita Medical seller in Q3 2021 was Driehaus Capital Management, an estimated $2.67M sold.
Based on aggregated 13F filings for Q3 2021.